Thyroid Update: New Concepts in the Diagnosis and Treatments of Thyroid Disease

Thyroid Update: New Concepts in the Diagnosis and Treatments of Thyroid Disease Banner


Date & Location
Friday, December 7, 2018, 7:00 AM - 5:00 PM, Kellogg Conference Hotel, Washington, DC

Target Audience
Emergency Medicine, Endocrinology, Family Medicine, Medical Oncology, Oncology, Radiation Oncology, Radiology, Surgery

Overview
Thyroid conditions such as hypothyroidism, hyperthyroidism, thyroid nodules and thyroid cancers are among the most common diseases encountered by physicians. This program aims to clarify the important issues surrounding the diagnosis and management of these common thyroid disorders. Guidelines on hypothyroidism, thyroid nodules as well as well-differentiated and medulary thyroid cancer have been recently updated. This conference will utilize and encourage the use of a multidisciplinary approach to educate clinicians about current and controversial issues in thyroid disease and will provide an opportunity for providers to become familiar with the key elements of the updated guidelines and incorporate them into their clinical practice. 

Target Audience

This conference is intended for practicing endocrinologists, surgeons, pathologists, internists, oncologists, gynecologists, obstetricians, otolaryngologists, as well as primary care and nuclear medicine physicians, radiologists, radiation oncologists, residents, fellows, nurse practitioners, physicians assistants, nurses and other members of the healthcare team interested in the diagnosis and treatment of thyroid disease.



Objectives
  1. Evaluate and compare the available molecular tests for thyroid nodules to determine which patients require thyroid surgery and which patients can be monitored
  2. Incorporate an interdisciplinary approach to the diagnosis and management of patients with thyroid disease
  3. Evaluate and select newly approved targeted oral chemotherapy agents, including TKIs, for the treatment of locally advanced or metastatic thyroid cancer refractory to radioiodine therapy
  4. Apply new radiation therapies including proton beam therapy
  5. Recognize the proper application of serum thyroglobulin levels
  6. Utilize stratified risk assessment for thyroid cancer
  7. Identify proper thyroid cancer patient selection for monitoring, lobectomy or total thyroidectomy
  8. Implement ATA Guideline recommendations for evaluation and management of autoimmune thyroid disease including thyroid disease in pregnancy
  9. Implement ATA Guideline recommendations for evaluation and management of thyroid nodules and thyroid cancer

Registration

Physician: $250
Resident/Fellow: $125
Physician Assistant: $150
Nurse Practitioner: $150
Nurse: $150
Allied Health Professional $150



Accreditation

In support of improving patient care, MedStar Health is jointly accredited by the Accreditation Council for Continuing Medical Education (ACCME), the Accreditation Council for Pharmacy Education (ACPE), the American Nurses Credentialing Center (ANCC) and the American Academy of PAs (AAPA) to provide continuing education for the healthcare team.

Credit Designation

This activity was planned by and for the healthcare team, and learners will receive 8.25 Interprofessional Continuing Education (IPCE) credits for learning and change.